More than 5,000 cancer patients in the United Kingdom recently learned that their government healthcare program will no longer pay for many of the most-effective life-extending drug treatments. Many of these patients must live with the knowledge that they may now die much sooner than they would have if they had access to these vital treatments.

While this news involves overseas cancer patients, the reality is that America’s seniors could soon face a similar fate under the Medicare program.

Since the start of the year, the United Kingdom’s publicly funded National Health Service has ceased funding two-thirds of the drug treatments that were recently available to patients under the Cancer Drugs Fund. The fund was established to allow cancer patients in England to apply for treatments deemed not effective or economical enough for the government’s liking, despite the fact that these drug treatments are standard in many other European countries and the United States.

Read the article “Is UK-Style Cancer Drug Rationing Coming to America Soon?” on washingtonexaminer.com.